Michelle Dipp

Investment Partner , Angel

Overview

Gender
female
Investor Type
Investment Partner,Angel
Investor Stage
Private Equity,Venture

Michelle Dipp, MD PhD is Co-Founder and Managing Partner at Biospring Partners, a life sciences technology growth equity firm. Michelle serves on the Board of Directors for Abzena.

Michelle was a Managing Director at General Atlantic, a New York based global growth equity firm. Michelle Dipp launched their life sciences investment platform and was a member of the life sciences investment committee. Michelle Dipp served as a Board Observer for Ginkgo BioWorks and also served as a board member for PathAI and Immunocore.

Michelle was a Co-Founder and former General Partner of a leading Boston-based healthcare investment firm, Longwood Fund. As a General Partner in Longwood Funds I, II, III, and IV, Michelle co-founded several portfolio companies for Longwood Fund, where she held senior management positions. In addition to her management positions, Michelle worked on the board of these portfolio companies including as Chairman of Axial Biotherapeutics. Michelle served on the board of Colorescience and also served as a board observer of both Bicycle Therapeutics and Pulmocide Ltd.

Before joining Longwood, Michelle Dipp was GlaxoSmithKline’s (GSK) Senior Vice President of the Centre of Excellence for External Drug Discovery (CEEDD). During Michelle Dipp's time she also served in GSK’s global business development group as Vice President of Corporate Development at Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT was ultimately acquired by GlaxoSmithKline in 2008).

Michelle began her investment career at the Wellcome Trust after completing her medical training. Michelle Dipp, MDPhD holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford, Brasenose College.

Michelle currently serves on the Trustee Advisory Board for Beth Israel Deaconess Medical Center; Advisory Board for the Women’s Foundation of Boston; Board of Directors for Life Science Cares; Rockefeller University Council; Advisory Council for the American Museum of Natural History; Co-Founding Member of the Bowman Fund, Brasenose College Boat Club, Oxford University; and a member of the World Economic Forum’s Young Global Leaders.

Personal Investments

Number of Investments
1
Michelle Dipp has made 1 investments. Their most recent investment was on Nov 6, 2019, when Digits raised $10.50M.
Date Company Name Round Money Raised Industry
Nov 6, 2019 Digits Series A $10.50M Artificial Intelligence Detail